Search Results - DEFEAT-LD Study Group

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets

    Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets by Giuseppe d’Orsi, Antonella Liantonio, Paola Imbrici, Nicola Gambacorta, Giorgia Dinoi, Cosimo Damiano Altomare, DEFEAT-LD Study Group, Massimo Carella

    Published 2025-05-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient

    Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient by Gabriele Trentini, Giulia Cazzanelli, Marina Cardano, Orazio Palumbo, Mario Benvenuto, Pietro Palumbo, Francesca Agriesti, Claudia Piccoli, Luciano Conti, DEFEAT-LD Study Group, Massimo Carella, Graziano Lolli, Giuseppe d’Orsi

    Published 2025-09-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: